Microbiology & Infectious Diseases

Carbapenem-resistant Enterobacterales infections are on the rise across Europe, with experts warning of worsening transmission and increasing resistance.

Pseudomonas aeruginosa infection drives lung transplant rejection by inducing regulatory T cell death and promoting B cell responses.

The NHS has expanded its mpox vaccination programme across England, opening 12 new sites to improve access for those at higher risk of infection.

A new clinical practice guideline for well-appearing febrile infants has led to a reduction in hospitalisations, antibiotic use, and invasive procedures.

Individuals who experience multiple COVID-19 infections are at greater risk of developing post-acute sequelae of COVID-19.

Research has identified microRNAs as potential biomarkers for predicting COVID-19-related mortality in patients with cancer.

Nasal microbiota transplantation could revolutionise the treatment of chronic rhinosinusitis and respiratory tract infections.

Aztreonam–avibactam is a promising treatment for complicated intra-abdominal infections and hospital-acquired or ventilator-associated pneumonia caused by Gram-negative bacteria.